A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Cancer Care Outcomes Data Bookmark and Share

Cancer Care Outcomes Data

Patient survival outcomes presented in this website have been compared to national statistics.  Our team of doctors, nurses and scientists produce outstanding results and we stand more determined than ever to find new treatments and cures for cancer.  The goal of curing cancer isn’t just something we work at.  It’s what we live for.
 

Breast Cancer Survival

For women who have been diagnosed with breast cancer, we’re ahead of the curve in providing better options that can lead to higher survival rates.  These options include surgical, medical and radiation therapies.
 
City of Hope is one of the few hospitals providing the latest advances in radiation therapy for breast cancer patients — intraoperative radiation therapy, or IORT. During surgery, patients receive a concentrated dose of precise radiation, rather than the normal follow up plan of six to eight weeks of daily radiation treatments.  IORT allows one day as opposed to six to eight weeks of daily radiation, with the exact same excellent results.
 
In addition, we have an extensive research program for women with breast cancer with more than 20 clinical trials, to help women find the right treatment for them.
 
A national database of cancer outcomes is maintained jointly by the American Cancer Society and the American College of Surgeons’ Commission on Cancer.  Each year, the National Cancer Database (NCDB) provides data to hospitals to allow each institution to compare its results with those obtained nationally.
 
The chart below compares survivorship over a five year period for City of Hope patients, who have had breast cancer and were treated by surgery, with patients nationally who have had the same treatment for the same stages of their disease.
 
At City of Hope, our survivorship exceeds the survival rates for patients treated at other cancer programs that report to the Commission on Cancer (CoC). 
Data include both patients diagnosed at City of Hope and those who visit post-diagnosis as well as initial treatment elsewhere.   Higher curves for City of Hope indicate better survival results, reflecting excellent care at City of Hope.  Although some variation between the curves may also be due to timing of referral to City of Hope, and other details of the patients’ situations.
 
 

Prostate Cancer Survival

Cancer of the prostate gland is a serious health risk for men. In fact, this year more than 238,000 American men will be diagnosed. The good news is that prostate cancer is the most survivable form of cancer in men, especially if it is detected early, before it can spread.
 
As a patient at City of Hope, your odds of surviving prostate cancer are excellent. Our innovative treatment options and technologies can help you recover faster, with fewer side effects.
 
A national database of cancer outcomes is maintained jointly by the American Cancer Society and the American College of Surgeons’ Commission on Cancer.  Each year, the National Cancer Database (NCDB) provides data to hospitals to allow each institution to compare its results with those obtained nationally.
 
The chart below compares survivorship over a five year period for City of Hope patients, who have had stage II or III prostate cancer and were treated by surgery, with patients nationally who have had the same treatment for the same stages of their disease.
 
At City of Hope, our survivorship exceeds the survival rate of patients treated at other cancer programs that report their data to the Commission on Cancer (CoC).  For Stages I and IV Prostate Cancer, there is insufficient data to track survivorship.
 
Data include both patients diagnosed at City of Hope and those who visit post-diagnosis as well as initial treatment elsewhere.   Higher curves for City of Hope indicate better survival results, reflecting excellent care at City of Hope.  Although some variation between the curves may also be due to timing of referral to City of Hope, and other details of the patients’ situations.
Survivorship is of utmost importance at City of Hope, yet quality-of-life is equally important.  The statistics below provide insight to continence and potency after surgery for prostate cancer at City of Hope.

Time to Continence
 
a) Greater than 90% of men less than 65 years of age achieve bladder control within one year.
b) Median time to achieve bladder control is 1.5 months after catheter removal.
c) Of all men who have prostatectomy, only 2% require a procedure to achieve bladder control.

Time to Potency

a) Approximately 73% of all patients are potent at two years.
b) Approximately 87% of men less than 55 years of age are potent at two years.
c) Approximately 75% of men 55-64 years of age are potent at two years.
 
 
 

Colon Cancer Survival

City of Hope brings together the most advanced resources to manage the treatment of patients with either early or advanced colorectal cancers. Our multidisciplinary team includes gastroenterologists, medical oncologists, radiation oncologists and surgical oncologists working cooperatively to create the most effective treatment plan.
 
A national database of cancer outcomes is maintained jointly by the American Cancer Society and the American College of Surgeons’ Commission on Cancer.  Each year, the National Cancer Database (NCDB) provides data to hospitals to allow each institution to compare its results with those obtained nationally.
 
The chart below compares survivorship over a five year period for City of Hope patients, who have had stage III or IV colon cancer and were treated by surgery, with patients nationally who have had the same treatment for the same stages of their disease.
 
At City of Hope, our survivorship exceeds the survival rates of patients treated at other cancer programs that report their data to the Commission on Cancer (CoC). For Stages I and II Colon Cancer, there is insufficient data to track survivorship over a five year period.
 

 
 
Data include both patients diagnosed at City of Hope and those who visit post-diagnosis as well as initial treatment elsewhere.   Higher curves for City of Hope indicate better survival results, reflecting excellent care at City of Hope.  Although some variation between the curves may also be due to timing of referral to City of Hope, and other details of the patients’ situations.
 
 

Cancer Care Outcomes Data

Cancer Care Outcomes Data

Patient survival outcomes presented in this website have been compared to national statistics.  Our team of doctors, nurses and scientists produce outstanding results and we stand more determined than ever to find new treatments and cures for cancer.  The goal of curing cancer isn’t just something we work at.  It’s what we live for.
 

Breast Cancer Survivorship

Breast Cancer Survival

For women who have been diagnosed with breast cancer, we’re ahead of the curve in providing better options that can lead to higher survival rates.  These options include surgical, medical and radiation therapies.
 
City of Hope is one of the few hospitals providing the latest advances in radiation therapy for breast cancer patients — intraoperative radiation therapy, or IORT. During surgery, patients receive a concentrated dose of precise radiation, rather than the normal follow up plan of six to eight weeks of daily radiation treatments.  IORT allows one day as opposed to six to eight weeks of daily radiation, with the exact same excellent results.
 
In addition, we have an extensive research program for women with breast cancer with more than 20 clinical trials, to help women find the right treatment for them.
 
A national database of cancer outcomes is maintained jointly by the American Cancer Society and the American College of Surgeons’ Commission on Cancer.  Each year, the National Cancer Database (NCDB) provides data to hospitals to allow each institution to compare its results with those obtained nationally.
 
The chart below compares survivorship over a five year period for City of Hope patients, who have had breast cancer and were treated by surgery, with patients nationally who have had the same treatment for the same stages of their disease.
 
At City of Hope, our survivorship exceeds the survival rates for patients treated at other cancer programs that report to the Commission on Cancer (CoC). 
Data include both patients diagnosed at City of Hope and those who visit post-diagnosis as well as initial treatment elsewhere.   Higher curves for City of Hope indicate better survival results, reflecting excellent care at City of Hope.  Although some variation between the curves may also be due to timing of referral to City of Hope, and other details of the patients’ situations.
 
 

Prostate Cancer Survivorship

Prostate Cancer Survival

Cancer of the prostate gland is a serious health risk for men. In fact, this year more than 238,000 American men will be diagnosed. The good news is that prostate cancer is the most survivable form of cancer in men, especially if it is detected early, before it can spread.
 
As a patient at City of Hope, your odds of surviving prostate cancer are excellent. Our innovative treatment options and technologies can help you recover faster, with fewer side effects.
 
A national database of cancer outcomes is maintained jointly by the American Cancer Society and the American College of Surgeons’ Commission on Cancer.  Each year, the National Cancer Database (NCDB) provides data to hospitals to allow each institution to compare its results with those obtained nationally.
 
The chart below compares survivorship over a five year period for City of Hope patients, who have had stage II or III prostate cancer and were treated by surgery, with patients nationally who have had the same treatment for the same stages of their disease.
 
At City of Hope, our survivorship exceeds the survival rate of patients treated at other cancer programs that report their data to the Commission on Cancer (CoC).  For Stages I and IV Prostate Cancer, there is insufficient data to track survivorship.
 
Data include both patients diagnosed at City of Hope and those who visit post-diagnosis as well as initial treatment elsewhere.   Higher curves for City of Hope indicate better survival results, reflecting excellent care at City of Hope.  Although some variation between the curves may also be due to timing of referral to City of Hope, and other details of the patients’ situations.
Survivorship is of utmost importance at City of Hope, yet quality-of-life is equally important.  The statistics below provide insight to continence and potency after surgery for prostate cancer at City of Hope.

Time to Continence
 
a) Greater than 90% of men less than 65 years of age achieve bladder control within one year.
b) Median time to achieve bladder control is 1.5 months after catheter removal.
c) Of all men who have prostatectomy, only 2% require a procedure to achieve bladder control.

Time to Potency

a) Approximately 73% of all patients are potent at two years.
b) Approximately 87% of men less than 55 years of age are potent at two years.
c) Approximately 75% of men 55-64 years of age are potent at two years.
 
 
 

Colon Cancer Survivorship

Colon Cancer Survival

City of Hope brings together the most advanced resources to manage the treatment of patients with either early or advanced colorectal cancers. Our multidisciplinary team includes gastroenterologists, medical oncologists, radiation oncologists and surgical oncologists working cooperatively to create the most effective treatment plan.
 
A national database of cancer outcomes is maintained jointly by the American Cancer Society and the American College of Surgeons’ Commission on Cancer.  Each year, the National Cancer Database (NCDB) provides data to hospitals to allow each institution to compare its results with those obtained nationally.
 
The chart below compares survivorship over a five year period for City of Hope patients, who have had stage III or IV colon cancer and were treated by surgery, with patients nationally who have had the same treatment for the same stages of their disease.
 
At City of Hope, our survivorship exceeds the survival rates of patients treated at other cancer programs that report their data to the Commission on Cancer (CoC). For Stages I and II Colon Cancer, there is insufficient data to track survivorship over a five year period.
 

 
 
Data include both patients diagnosed at City of Hope and those who visit post-diagnosis as well as initial treatment elsewhere.   Higher curves for City of Hope indicate better survival results, reflecting excellent care at City of Hope.  Although some variation between the curves may also be due to timing of referral to City of Hope, and other details of the patients’ situations.
 
 
Clinics/Treatments/Services
As a Comprehensive Cancer Center – the highest designation given by the National Cancer Institute – we are widely regarded as a leader in cancer prevention and treatment.

Refer a Patient
Physicians can choose a number of options to refer a patient:

 
Cancer Prevention
City of Hope combines compassionate care with the best and most innovative science. Our 100+ acre campus is designed to meet the full range of needs of our patients and families. This guide is designed to help you take advantage of all that is offered at City of Hope - Duarte.
To make an appointment for yourself, a family member or a friend, please complete and submit our Become a Patient Request Form, or call City of Hope at
800-826-HOPE (4673).
Contact Us
Phone: (800) 826-HOPE (4673)
 
Hours: M – F, 8 a.m. to 5 p.m. (PST)
 
Calls received after 5 p.m. will be returned the next business day.


NEWS & UPDATES
  • We’ve all heard the mantra: Cancer screening saves lives. And it does, especially with colorectal cancer. Regular colonoscopies have been proven to reduce the risk of colorectal cancer death by up to 70 percent. Screening for colorectal cancer using the even simpler fecal occult blood tests has been found to re...
  • Pick up any biotech industry report and you’re guaranteed to come across one term repeatedly – CAR-T therapy. A fierce competition is now underway to bring CAR-T treatments to market – several companies (Juno, Novartis, Kite and Cellectis, to name a few) have major stakes in the race. I’ve found the CAR-T buzz ...
  • Patients undergoing treatment at City of Hope know they will be receiving the best medical care available, that their treatment will be delivered with compassion and that their care will extend to their families. “When we treat a patient here, we treat a family,” says Jo Ann S. Namm, child life manager and spec...
  • Did you know that colorectal cancer equally affects men and women? Or that it’s the third-leading cause of cancer death in the U.S.? Most important, did you know that colorectal cancer is very treatable and highly curable if detected early? If you didn’t know these facts, it’s time to learn. M...
  • To celebrate the beginning of Lunar New  Year 2015, City of Hope honored not just a new lunar calendar, but also the diversity of the community it serves. On Jan. 21, as tens of thousands of people celebrated Lunar New Year (and the arrival of the Year of the Ram) in the streets of L.A.’s Chinatown, City of [&#...
  • The breakthroughs that have revolutionized cancer treatment, transforming cancer in many cases to a very manageable and even curable disease, started out as just ideas. “I will often tell patients there’s no therapy we’re using to help them that wasn’t derived from somebody’s idea in some laboratory, working la...
  • The prostate cancer screening debate, at least as it relates to regular assessment of prostate specific antigen levels, is far from over. The U.S. Preventive Services Task Force recommended against routine PSA screening for prostate cancer in 2012, maintaining that the routine use of the PSA blood test does mor...
  • Cancer patients should get more than medical treatment. They should get comprehensive, evidence-based care that addresses their full range of needs. That kind of patient-focused care is City of Hope’s specialty. Under the guidance of Dawn Gross, M.D., Ph.D., the new Arthur M. Coppola Family Chair in Suppo...
  • Think twice before tossing out those hormone replacement pills. Although a new Lancet study suggests that hormone replacement therapy could increase a woman’s risk of ovarian cancer, a City of Hope expert urges women to keep this news in perspective. Hormone replacement therapy is prescribed to help allev...
  • Don’t know what to take, or send, that friend of yours in the hospital? Try a paper plate — filled not with cookies or sweets, but an image of yourself. Ilana Massi, currently undergoing treatment at City of Hope for acute myeloid leukemia, can vouch for the power of such a gift. She’s surrounded herself [̷...
  • With precision medicine now a national priority, City of Hope has joined a novel research partnership designed to further understanding of cancer at the molecular level, ultimately leading to more targeted cancer treatments. The Oncology Research Information Exchange Network, or ORIEN, is the world’s larg...
  • The spinal cord is an integral part of the human body, connecting the brain to everything else. So when a tumor grows on the spine, any messages that the brain tries to send to the rest of the body are interrupted, making everyday tasks — such as walking — more difficult. This year an estimated 22,850 […]
  • Each year, thousands of patients with hematologic malignancies undergo allogeneic stem cell transplantation (that is, they receive a donor’s stem cells), offering them a chance at cure. Graft-versus-host disease is a potentially deadly complication of this therapy and occurs in approximately 25 to 60 perc...
  • Bertram Yuh, M.D., assistant clinical professor in the Division of Urology and Urologic Oncology at City of Hope, offers his perspective on the benefits of surgery for aggressive prostate cancer. For men walking out of the doctor’s office after a diagnosis of cancer, the reality can hit like a ton of bricks. Th...
  • Although many Hispanic women face a high risk of mutations in the BRCA1 and BRCA2 genes – increasing their risk of breast and ovarian cancer – screenings for these mutations can be prohibitively expensive in Mexico and other Latin American countries. As a result, too many women don’t get the information t...